Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP
about
sameAs
Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognitionDARPP-32: from neurotransmission to cancerMolecular targets for tumour progression in gastrointestinal stromal tumours.Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagusClustering of molecular alterations in gastroesophageal carcinomas.Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesisExpression of t-DARPP mediates trastuzumab resistance in breast cancer cells.Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy.Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis.Darpp-32 and t-Darpp are differentially expressed in normal and malignant mouse mammary tissue.t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer.Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells.High Expression of DARPP-32 in Colorectal Cancer Is Associated With Liver Metastases and Predicts Survival for Dukes A and B Patients: Results of a Pilot Study.Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases.DARPP-32, Jack of All Trades… Master of Which?DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib.Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.Calpain-mediated cleavage of DARPP-32 in Alzheimer's disease.Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesisA gene encoding an apurinic/apyrimidinic endonuclease-like protein is up-regulated in human gastric cancer.Regulation of ERBB2 receptor by t-DARPP mediates trastuzumab resistance in human esophageal adenocarcinoma.Trefoil factor 1 expression suppresses Helicobacter pylori-induced inflammation in gastric carcinogenesis.t-Darpp overexpression in HER2-positive breast cancer confers a survival advantage in lapatinib.Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cellsDARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinomaDarpp-32 and its truncated variant t-Darpp have antagonistic effects on breast cancer cell growth and herceptin resistance.Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner.Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines.Helicobacter pylori-induced cell death is counteracted by NF-κB-mediated transcription of DARPP-32t-Darpp stimulates protein kinase A activity by forming a complex with its RI regulatory subunit.Cellular localization and function of DARPP-32 in the rodent retinat-Darpp is an elongated monomer that binds calcium and is phosphorylated by cyclin-dependent kinases 1 and 5.Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types.DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration
P2860
Q24681770-9AC62F93-4BF8-4E0C-AE02-89261F9013FCQ26766237-C90B72CB-D398-46ED-A4F2-03651B7F52CCQ30312213-AC2061E1-F20E-46AE-9C88-3659FF43A83DQ30412980-07C76476-2879-4E5C-8427-960FDE1437ACQ30433528-57A5DAEE-715F-4828-A62B-0442CB9879EBQ30437572-DB214335-79C0-47CE-9C10-9B9B7CF354DDQ33743601-17CCA427-A0DC-48EA-91F1-48952CE7ABEFQ33932460-908D2319-BB69-4B2B-9CBB-165DF3C8029FQ34058585-16B8DC77-8DA2-44DA-ACB8-E35C166DD9B2Q34100269-FCACD5C8-57E1-4FCC-94ED-B52EAE223B64Q34156895-309F0697-7B85-4F81-9AE3-3D89CC1CF970Q34785283-58F5CC2C-716E-4704-9CCF-EFBFF43356FBQ35110657-36AD868A-FF9C-44EA-8222-AC9F23F5242CQ35182543-97A49AEC-5421-41BA-B28B-DC9C0A6560AFQ35201971-599F9597-DBF1-4138-8B92-4CF9EBA783EFQ35449387-74445E51-4056-46A9-92EF-70F2031BF16CQ35801261-E83EB2B6-59A3-4F43-81EA-079294EFCB55Q36057664-F5B62C80-E807-405A-AA1C-723A9ECCD670Q36069142-7DE2E1C4-8971-4474-B0E1-4099C476942EQ36179768-30BA4B26-3CEB-4F17-815A-BD02B993DAA0Q36205260-55A913C1-6589-461F-92C6-0E0047EC93ECQ36348877-ECFE120B-4E3D-47A8-9477-7DC4713F37BCQ36545095-C2AB2875-C99D-4358-8424-50E4E905EF54Q36553388-64000DBD-03E0-426B-BD12-63538E1BB42BQ36625979-2B641374-A506-40D7-A41E-516A4C3D14C9Q37248165-A5E0232C-A539-4403-8058-B95DA0C7B705Q37448108-A2CF57DB-7EC2-436A-8F2B-E5AE1259552EQ37455274-4240D05B-7E46-4737-83E3-71181B592989Q37678094-7E951C2D-A5EE-44EA-B9D0-344A4667F3C5Q38693444-7FF3E2FB-ED81-4576-810C-B59A39840725Q41478832-219246CB-B4A4-46FA-AEDF-DBFB4086147AQ41627665-0669FE72-2C84-4007-BF46-734A85C91ECFQ41844967-A0608431-7A4C-4BBA-8A77-1451F53D4937Q56815794-70B9AAA5-F8F5-4BD2-9726-277960FD5876
P2860
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP
@ast
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP
@en
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP
@nl
type
label
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP
@ast
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP
@en
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP
@nl
prefLabel
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP
@ast
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP
@en
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP
@nl
P2093
P1433
P1476
Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP
@en
P2093
Andy Beckler
Christopher A Moskaluk
Elizabeth Montgomery
Guolian Li
Henry F Frierson
Michael F Smith
Sakari Knuutila
Steven M Powell
Virginia S Carl
Wa'el El-Rifai
P304
P407
P577
2002-07-01T00:00:00Z